Back to Search
Start Over
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
- Source :
- Multiple Sclerosis and Related Disorders; 20210101, Issue: Preprints
- Publication Year :
- 2021
-
Abstract
- Some people with multiple sclerosis (pwMS) are at increased risk of severe Coronavirus disease 19 (COVID-19) and should be rapidly vaccinated. However, vaccine supplies are limited, and there are concerns about side-effects, particularly with the ChAdOx1nCoV-19 (AstraZeneca) vaccine.
Details
- Language :
- English
- ISSN :
- 22110348
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Multiple Sclerosis and Related Disorders
- Publication Type :
- Periodical
- Accession number :
- ejs56365144
- Full Text :
- https://doi.org/10.1016/j.msard.2021.103028